CDH17 and head and neck squamous cell carcinoma: My Mahoney (Thomas Jefferson University) discussed the role of the cadherin and cancer biomarker desmoglein 2 (Dsg2) in head and neck squamous cell carcinoma (HNSCC), especially in the context of therapy with immune checkpoint inhibitors (ICI).